John Overdeck’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-36,426
Closed -$45.9K 3334
2023
Q2
$45.9K Sell
36,426
-92,586
-72% -$150K ﹤0.01% 2840
2023
Q1
$258K Buy
129,012
+2,387
+2% +$4.48K ﹤0.01% 2486
2022
Q4
$167K Buy
+126,625
New +$162K ﹤0.01% 2427
2022
Q3
Sell
-14,907
Closed -$15K 2934
2022
Q2
$15K Sell
14,907
-36,021
-71% -$47.5K ﹤0.01% 2422
2022
Q1
$98K Sell
50,928
-48,532
-49% -$104K ﹤0.01% 2435
2021
Q4
$218K Sell
99,460
-10,399
-9% -$34.6K ﹤0.01% 3873
2021
Q3
$409K Sell
109,859
-55,102
-33% -$235K ﹤0.01% 3430
2021
Q2
$986K Sell
164,961
-65,677
-28% -$347K ﹤0.01% 2491
2021
Q1
$1.52M Buy
230,638
+58,918
+34% +$387K ﹤0.01% 1930
2020
Q4
$969K Buy
171,720
+31,282
+22% +$172K ﹤0.01% 2038
2020
Q3
$660K Buy
140,438
+60,350
+75% +$428K ﹤0.01% 2045
2020
Q2
$932K Sell
80,088
-48,277
-38% -$573K ﹤0.01% 1578
2020
Q1
$739K Sell
128,365
-23,433
-15% -$210K 0.01% 1653
2019
Q4
$2.08M Buy
+151,798
New +$1.34M 0.01% 1554
2019
Q1
Sell
-35,153
Closed -$124K 3561
2018
Q4
$124K Buy
35,153
+17,986
+105% +$103K ﹤0.01% 2788
2018
Q3
$144K Sell
17,167
-19,927
-54% -$210K ﹤0.01% 3053
2018
Q2
$451K Sell
37,094
-17,050
-31% -$176K ﹤0.01% 2716
2018
Q1
$536K Sell
54,144
-5,500
-9% -$61.9K ﹤0.01% 2435
2017
Q4
$787K Buy
+59,644
New +$768K ﹤0.01% 2130
2017
Q2
Sell
-15,709
Closed -$2.01M 3361
2017
Q1
$2.01M Buy
+15,709
New +$1.66M 0.01% 1454

Other funds holding ARAV

John Overdeck's ARAV Position: Q3 2023 in Review

John Overdeck sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2023, closing a stake of 36,426 shares — an estimated $45.9K sold.

John Overdeck first reported a position in ARAV in Q1 2017 and held it in 20 quarters. The position peaked at $2.08M in Q4 2019. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.

  • John Overdeck reported no remaining Aravive, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • John Overdeck sold 36,426 Aravive, Inc. Common Stock shares in Q3 2023, an estimated $45.9K.
  • John Overdeck first reported a position in Aravive, Inc. Common Stock in Q1 2017 and held it in 20 quarters.
  • John Overdeck's Aravive, Inc. Common Stock position peaked at $2.08M in Q4 2019.
  • 33 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.